Stockholm - Delayed Quote SEK

Neola Medical AB (publ) (NEOLA.ST)

2.5500
+0.1100
+(4.51%)
At close: May 21 at 2:56:25 PM GMT+2

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
NameTitlePayExercisedYear Born
Ms. Hanna Sjostrom CEO & MD -- -- 1979
Mr. David Folkesson Chief Financial Officer -- -- --
Ms. Sara Bergsten Chief Technology Officer -- -- 1973
Mr. Magnus Johnsson Director Quality Assurance & Regulatory Affairs -- -- 1975

Neola Medical AB (publ)

Ideon Gateway
Scheelevägen 27
Lund, 223 63
Sweden
https://www.neolamedical.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
8

Description

Neola Medical AB (publ), together with its subsidiary, Neola Medical, Inc., develops medical technology devices for non-invasive continuous monitoring of the lungs of preterm born infants in Sweden. It offers NEOLA, a neonatal intensive care medical device that enables continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. The company was formerly known as GPX Medical AB and changed its name to Neola Medical AB (publ) in June 2022. Neola Medical AB (publ) was incorporated in 2016 and is headquartered in Lund, Sweden.

Corporate Governance

Neola Medical AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers